Survey: U.S. patient groups have low opinion of drugmaker marketing ethics

04/8/2013 | PharmaLive.com

Half of 70 U.S.-based patient groups surveyed said drugmakers are innovative, and 59% said drugmakers are good or excellent at creating high-quality, useful products. But 76% said drugmakers have fair or poor ethics in marketing, and only 10% said the industry is transparent. In the U.K., 70% of 80 patient groups surveyed rated drugmakers as good or excellent at making high-quality, useful products and 72% rated ethics in industry marketing as fair or poor.

View Full Article in:

PharmaLive.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX